Revision history of "NANJING HANXIN PHARMACEUTICAL TECHNOLOGY CO., LTD. (20240343772). Fusion protein and its preparation method for intermediate polypeptide of Semaglutide simplified abstract"

Jump to navigation Jump to search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.